Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
Plos Medicine|March 29, 2017
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon, et al.
Neurology|May 13, 2021
Primary Progressive Aphasia Associated With <i>GRN</i> Mutations: New Insights Into the Nonamyloid Logopenic VariantDario Saracino, Sophie Ferrieux, Marie Noguès-Lassiaille, et al.
Alzheimer'S Research & Therapy|August 31, 2017
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohortCarole Dufouil, Bruno Dubois, Bruno Vellas, et al.
Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
European Journal of Human Genetics : EJHG|August 6, 2015
Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessonsGaël Nicolas, David Wallon, Camille Charbonnier, et al.
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2022
Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR studyOlivier Hanon, Jean-Sébastien Vidal, Sylvain Lehmann, et al.
Plos Medicine|March 29, 2017
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon, et al.
Neurology|May 13, 2021
Primary Progressive Aphasia Associated With <i>GRN</i> Mutations: New Insights Into the Nonamyloid Logopenic VariantDario Saracino, Sophie Ferrieux, Marie Noguès-Lassiaille, et al.
Alzheimer'S Research & Therapy|August 31, 2017
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohortCarole Dufouil, Bruno Dubois, Bruno Vellas, et al.
Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
European Journal of Human Genetics : EJHG|August 6, 2015
Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessonsGaël Nicolas, David Wallon, Camille Charbonnier, et al.
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Pageof 18